デフォルト表紙
市場調査レポート
商品コード
1619095

ラベルフリー検出の市場規模、シェア、成長分析、製品別、技術別、用途別、エンドユーザー別、地域別 - 産業別予測、2024~2031年

Label Free Detection Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Technology (Bio-Layer Interferometry, Differential Scanning Calorimetry), By Application, By End-User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 242 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ラベルフリー検出の市場規模、シェア、成長分析、製品別、技術別、用途別、エンドユーザー別、地域別 - 産業別予測、2024~2031年
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ラベルフリー検出の世界市場規模は、2022年に15億米ドルと評価され、2023年の16億2,000万米ドルから2031年には30億5,000万米ドルに成長し、予測期間(2024~2031年)のCAGRは8.2%で成長する見通しです。

ラベルフリー検出システム市場は、自動蛍光やラベルを使用せずに生体分子相互作用の研究を可能にする技術の進歩によって、大きな成長が見込まれています。これらのシステムは迅速でリアルタイムの創薬を促進し、生化学的および細胞ベースのアッセイで主に利用されています。2021年から2028年にかけて、創薬プログラムの強化を目的とした産学連携の急増が市場拡大をさらに促進すると予想されます。さらに、研究資金の増加とラベルフリー技術固有の高感度が成長を支えると思われます。製薬およびバイオテクノロジーの研究開発環境の拡大と、エンドユーザーにおけるラベルフリー法の利点に対する認識の高まりが相まって、予測期間を通じて市場の堅調な開拓が確実視されます。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術の進歩
  • 規制情勢
  • 特許分析
  • ケーススタディ

ラベルフリー検出市場規模:製品別およびCAGR(2024~2031年)

  • 市場概要
  • 消耗品
    • バイオセンサーチップ
    • マイクロプレート
  • 機器

ラベルフリー検出市場規模:技術別およびCAGR(2024~2031年)

  • 市場概要
  • バイオレイヤー干渉法
  • 示差走査熱量測定
  • 等温滴定熱量測定
  • 表面プラズモン共鳴
  • 質量分析
  • その他のLFD技術

ラベルフリー検出市場規模:用途別およびCAGR(2024~2031年)

  • 市場概要
  • 結合動態
  • 結合熱力学
  • 内因性受容体の検出
  • ヒット確認
  • リード創出
  • その他

ラベルフリー検出市場規模:エンドユーザー別およびCAGR(2024~2031年)

  • 市場概要
  • 製薬・バイオテクノロジー企業
  • 学術調査機関
  • 契約調査機関

ラベルフリー検出市場規模およびCAGR(2024~2031年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2021~2023年)

主要企業プロファイル

  • Agilent Technologies, Inc.(USA)
  • Danaher Corporation(USA)
  • PerkinElmer, Inc.(USA)
  • GE Healthcare(USA)
  • Thermo Fisher Scientific Inc.(USA)
  • Bio-Rad Laboratories, Inc.(USA)
  • F. Hoffmann-La Roche AG(Switzerland)
  • Horiba, Ltd.(Japan)
  • Malvern Panalytical Ltd.(UK)
  • Bruker Corporation(USA)
  • Waters Corporation(USA)
  • Shimadzu Corporation(Japan)
  • Corning Incorporated(USA)
  • Hitachi High-Tech Corporation(Japan)
  • Molecular Devices, LLC(USA)
  • Sartorius AG(Germany)
  • BiOptix Analytical LLC(USA)
  • Attana AB(Sweden)
  • XanTec Bioanalytics GmbH(Germany)

結論と推奨事項

目次
Product Code: SQMIG35I2221

Global Label Free Detection Market size was valued at USD 1.5 billion in 2022 and is poised to grow from USD 1.62 billion in 2023 to USD 3.05 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).

The label-free detection systems market is poised for significant growth, driven by advancements in technology that enable the study of biomolecular interactions without auto-fluorescence or labels. These systems facilitate rapid, real-time drug discovery and are predominantly utilized in biochemical and cell-based assays. From 2021 to 2028, a surge in academic-industrial partnerships aimed at bolstering drug discovery programs is expected to further propel market expansion. Additionally, increased funding for research and the inherent high sensitivity of label-free technologies will support growth. The expanding pharmaceutical and biotechnology R&D landscape, coupled with rising awareness of label-free methods' advantages among end-users, will ensure robust market development throughout the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Label Free Detection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Label Free Detection Market Segmental Analysis

Global Label Free Detection Market is segmented by product, technology, application, end-user and region. Based on product, the market is segmented into consumables and instruments. Based on technology, the market is segmented into bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, surface plasmon resonance, mass spectrometry and other LFD technologies. Based on application, the market is segmented into binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation and other. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and contract research organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Label Free Detection Market

The Global Label Free Detection market is poised for significant growth, driven largely by advancements in life sciences and the emergence of more sensitive technologies that do not rely on markers. The expansion of life sciences research in developing regions is creating a plethora of development opportunities for companies involved in this sector. Additionally, the introduction of innovative technological products and the increasing preference for efficient product delivery mechanisms are acting as catalysts for market growth. Label-free detection methods allow for the exploration of molecular interactions without the limitations associated with traditional labeling, such as quenching effects, spatial interference, or autofluorescence, making these technologies an attractive option in high throughput screening applications.

Restraints in the Global Label Free Detection Market

The global label-free detection market faces notable constraints that may impede its growth. A primary challenge is the elevated cost of the instruments required for label-free detection, which can deter potential users and limit market adoption. Additionally, the lack of awareness regarding the benefits and applications of label-free detection technologies further contributes to the market's slow expansion. This combination of high financial barriers and insufficient understanding hinders the market's ability to reach its full potential, preventing broader integration and acceptance of label-free detection methods across various sectors. Addressing these issues is crucial for facilitating market growth.

Market Trends of the Global Label Free Detection Market

The Global Label-Free Detection market is experiencing robust growth driven by technological innovations and strategic collaborations. Key techniques like bio-layer interferometry (BLI) and surface plasmon resonance (SPR) are gaining traction, with advancements such as Corning(R) Epic(R) BT leading the charge. This cutting-edge benchtop model streamlines cell-based and biochemical assays, boasts a competitive price, and features user-friendly data collection software, enabling greater accessibility for researchers, including those in academic settings. Partnerships, notably between Corning and Advinus Therapeutics, enhance market reach by facilitating drug discovery processes and assay services globally. As a result, the Label-Free Detection market is poised for significant expansion during the forecast period.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies

Global Label Free Detection Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Consumables
    • Biosensor Chips
    • Microplates
  • Instruments

Global Label Free Detection Market Size by Technology & CAGR (2024-2031)

  • Market Overview
  • Bio-Layer Interferometry
  • Differential Scanning Calorimetry
  • Isothermal Titration Calorimetry
  • Surface Plasmon Resonance
  • Mass Spectrometry
  • Other LFD Technologies

Global Label Free Detection Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Binding Kinetics
  • Binding Thermodynamics
  • Endogenous Receptor Detection
  • Hit Confirmation
  • Lead Generation
  • Other

Global Label Free Detection Market Size by End-User & CAGR (2024-2031)

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations

Global Label Free Detection Market Size & CAGR (2024-2031)

  • North America (Product, Technology, Application, End-User)
    • USA
    • Canada
  • Europe (Product, Technology, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Technology, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Technology, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Technology, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Horiba, Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Malvern Panalytical Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Waters Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corning Incorporated (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi High-Tech Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molecular Devices, LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BiOptix Analytical LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Attana AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • XanTec Bioanalytics GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations